These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11726032)

  • 21. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
    Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
    Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of highly stable IL-18 based on a ligand-receptor complex structure.
    Yamamoto Y; Kato Z; Matsukuma E; Li A; Omoya K; Hashimoto K; Ohnishi H; Kondo N
    Biochem Biophys Res Commun; 2004 Apr; 317(1):181-6. PubMed ID: 15047165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular therapy versus standard treatment in allergy (Review).
    Grzela K; Lazarczyk M; Dziunycz P; Milewski L; Niderla J; Grzela T
    Int J Mol Med; 2004 Jul; 14(1):3-22. PubMed ID: 15202012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulation: the future cure for allergic diseases.
    Tsitoura DC; Tassios Y
    Ann N Y Acad Sci; 2006 Nov; 1088():100-15. PubMed ID: 17192559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity.
    Acres B; Gantzer M; Remy C; Futin N; Accart N; Chaloin O; Hoebeke J; Balloul JM; Paul S
    Cancer Res; 2005 Oct; 65(20):9536-46. PubMed ID: 16230419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y
    Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
    Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
    Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children.
    Cherñavsky AC; Paladino N; Rubio AE; De Biasio MB; Periolo N; Cuarterolo M; Goñi J; Galoppo C; Cañero-Velasco MC; Muñoz AE; Fainboim H; Fainboim L
    Hum Immunol; 2004 Jul; 65(7):683-91. PubMed ID: 15301856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR9-based immunotherapy for allergic disease.
    Hayashi T; Raz E
    Am J Med; 2006 Oct; 119(10):897.e1-6. PubMed ID: 17000223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin-10-treated dendritic cells and transforming growth factor-beta for their induction.
    Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
    Clin Exp Allergy; 2006 Dec; 36(12):1546-55. PubMed ID: 17177678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    Yoshimoto T; Min B; Sugimoto T; Hayashi N; Ishikawa Y; Sasaki Y; Hata H; Takeda K; Okumura K; Van Kaer L; Paul WE; Nakanishi K
    J Exp Med; 2003 Apr; 197(8):997-1005. PubMed ID: 12695491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells as potential immunotherapy in allergy.
    Wing K; Sakaguchi S
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):482-8. PubMed ID: 17088656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New therapeutic strategies, a chimeric fusion protein inhibits allergic reactivity].
    Terada T
    Nihon Rinsho; 2009 Nov; 67(11):2178-82. PubMed ID: 19899537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-based immunotherapy to treat atopic disease.
    Tsalik EL
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):403-10; quiz 410-1, 451. PubMed ID: 16312161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytokines in the treatment of a generalized surgical infection].
    Pal'tsev AV; Ovechkin AV; Zakharova NF; Rovina AK; Leplina OIu; Shevela EIa; Ostanin AA; Chernykh ER
    Anesteziol Reanimatol; 2000; (2):27-30. PubMed ID: 10833832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunotherapy of allergic manifestations].
    Tassi GC; Sacchi G
    Boll Ist Sieroter Milan; 1983 Mar; 62(1):1-36. PubMed ID: 6357228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-4 may unlock asthma and allergic diseases.
    Kling J
    Nat Biotechnol; 1997 Apr; 15(4):316-7. PubMed ID: 9094124
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of interleukin 10 in the regulation of allergic immune responses.
    Bellinghausen I; Knop J; Saloga J
    Int Arch Allergy Immunol; 2001 Oct; 126(2):97-101. PubMed ID: 11729346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The mucosal immune system: new strategy for the control of allergic diseases].
    Sato A; Kiyono H
    Nihon Rinsho; 2009 Nov; 67(11):2194-9. PubMed ID: 19899540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.